| Quantitative correlation between cellular proliferation and nuclear poly (ADP-ribose) polymerase (PARP-1). | |
| | |
MedLine Citation:
|
PMID: 16391829 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
Treatment of cells with lysophosphatidyl choline and centrifugal extraction can separate poly (ADP-ribose) synthetase (PARP-1) and DNA synthetase activities, permitting the experimental analysis and comparison of both multienzyme systems. Only PARP-1 is being assayed by our system. Ca(2+) and Mg(2+) have minor activating effects, and added histones are without activating action. Short end-blocked dsDNAs at nM concentrations and spermine at mM concentrations are maximally activating coenzymes of poly (ADP-ribose) synthesis. Comparison of non-proliferating non-malignant cells with rapidly growing cancer cells demonstrates that rates of poly (ADP-ribose) synthesis and DNA synthesis are highest in pre-confluent non-malignant cells and in proliferating cancer cells, and lowest in contact-inhibited non-malignant cells. Rates of poly (ADP-ribose) synthesis correlate with the number of enzymatically activable PARP-1 molecules per cell, determined under Vmax conditions where activity is linearly proportional to enzyme protein. Contact-inhibited non-malignant cells exhibit only trans-ADP-ribosylation that is not affected by ATP, while rapid growth, especially in cancer cells, demonstrates extensive auto-poly (ADP)-ribosylation that is strongly inhibited by ATP at concentrations present in cells exhibiting normal bioenergetics. Rates of mRNA synthesis in non-proliferating non-malignant cells and in cancer cells were indistinguishable, indicating that the differences observed between cellular phenotypes are most likely due to reassembly of PARP-1 molecules in nuclei to homo-dimers (in cancer cells) and hetero-dimers (in non-cancer cells). A specific inhibitor and an inactivator of PARP-1 each inhibit DNA synthesis when intact cancer cells are pretreated with these drugs. Direct addition of these drugs to permeabilized cells performing DNA synthesis has no effect on DNA synthesis. The most striking diagnostic signal for cancer cells is activation of PARP-1 and of DNA synthesis. |
| | |
Authors:
|
Ernest Kun; Eva Kirsten; Pal I Bauer; Charles P Ordahl |
Related Documents
:
|
21407219 - Chronic exposure of colorectal cancer cells to bevacizumab promotes compensatory pathwa... 2702649 - Antitumor effect of a new multienzyme inhibitor of polyamine synthetic pathway, methylg... 20435139 - Pegylation of biodegradable dextran nanogels for sirna delivery. 2504149 - Polyamine depletion is associated with altered chromatin structure in hela cells. 16809299 - The double-stranded rna binding protein 76:nf45 heterodimer inhibits translation initia... 22422649 - Mangiferin aglycone attenuates radiation-induced damage on human intestinal epithelial ... 20875729 - Electric cell-substrate impedance sensing (ecis) based real-time measurement of titer d... 6502269 - Protective effect of taurine, zinc and tocopherol on retinol-induced damage in human ly... 21602799 - High-throughput analysis of single hematopoietic stem cell proliferation in microfluidi... |
Publication Detail:
|
Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: International journal of molecular medicine Volume: 17 ISSN: 1107-3756 ISO Abbreviation: Int. J. Mol. Med. Publication Date: 2006 Feb |
Date Detail:
|
Created Date: 2006-01-04 Completed Date: 2006-03-02 Revised Date: 2007-11-14 |
Medline Journal Info:
|
Nlm Unique ID: 9810955 Medline TA: Int J Mol Med Country: Greece |
Other Details:
|
Languages: eng Pagination: 293-300 Citation Subset: IM |
Affiliation:
|
Department of Anatomy, School of Medicine, University of California San Francisco Medical Center, San Francisco, CA 94143, USA. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Animals Cell Line Cell Proliferation Cercopithecus aethiops DNA / biosynthesis Electrophoresis, Gel, Two-Dimensional Kinetics Neoplasms / metabolism, pathology Poly(ADP-ribose) Polymerases / genetics, metabolism* RNA, Messenger / genetics, metabolism |
| Grant Support | |
ID/Acronym/Agency:
|
HL 35561/HL/NHLBI NIH HHS; HL 59693/HL/NHLBI NIH HHS |
| Chemical | |
Reg. No./Substance:
|
0/RNA, Messenger; 9007-49-2/DNA; EC 2.4.2.30/Poly(ADP-ribose) Polymerases |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Alteration of gene expression in response to bone morphogenetic protein-2 in androgen-dependent huma...
Next Document: In vitro analysis of integrin expression during chondrogenic differentiation of mesenchymal stem cel...